Invivyd

Invivyd is a biopharmaceutical company dedicated to delivering protection from serious viral infectious diseases. Utilizing their Invymab™ platform, Invivyd leverages state-of-the-art viral surveillance, predictive modeling, and advanced antibody engineering techniques to continuously discover and optimize monoclonal antibody candidates. These antibodies are designed to protect vulnerable populations from significant viral threats, such as COVID-19 and influenza. The company emphasizes a platform-based approach to develop a robust pipeline of candidates for both prevention and treatment of such diseases.